Novartis AG ADR (NVS): Price and Financial Metrics
NVS Price/Volume Stats
| Current price | $97.74 | 52-week high | $108.78 |
| Prev. close | $97.28 | 52-week low | $92.19 |
| Day low | $97.41 | Volume | 1,074,947 |
| Day high | $98.55 | Avg. volume | 1,534,004 |
| 50-day MA | $97.95 | Dividend yield | 2.58% |
| 200-day MA | $99.76 | Market Cap | 199.78B |
NVS Stock Price Chart Interactive Chart >
Novartis AG ADR (NVS) Company Bio
Novartis AG is a Swiss-American multinational pharmaceutical corporation based in Basel, Switzerland and Cambridge, Massachusetts, United States (global research). It is one of the largest pharmaceutical companies in the world. (Source:Wikipedia)
Latest NVS News From Around the Web
Below are the latest news stories about NOVARTIS AG that investors may wish to consider to help them evaluate NVS as an investment opportunity.
Why Is Cytokinetics (CYTK) Stock Up 70% Today?With Cytokinetics hitting a homerun with its heart failure drug, CYTK stock skyrocketed in part due to takeover interest. |
Novartis (NVS) Outperforms Broader Market: What You Need to KnowNovartis (NVS) closed at $99.71 in the latest trading session, marking a +1.18% move from the prior day. |
The Zacks Analyst Blog Highlights Procter & Gamble, PepsiCo, Novartis, Occidental Petroleum and DuPont de NemoursProcter & Gamble, PepsiCo, Novartis, Occidental Petroleum and DuPont de Nemours are part of the Zacks top Analyst Blog. |
Novartis (NVS) Stock Moves -1.17%: What You Should KnowNovartis (NVS) closed the most recent trading day at $97.14, moving -1.17% from the previous trading session. |
Roche's (RHHBY) sBLA for Xolair Gets FDA Priority Review TagThe FDA accepts and grants priority review to Roche's (RHHBY) supplemental biologics license application for Xolair for the reduction of food allergic reactions. A decision is due in the first quarter of 2024. |
NVS Price Returns
| 1-mo | 2.10% |
| 3-mo | -6.43% |
| 6-mo | 8.50% |
| 1-year | 1.69% |
| 3-year | 26.49% |
| 5-year | 44.02% |
| YTD | -0.85% |
| 2023 | 20.92% |
| 2022 | 6.47% |
| 2021 | -5.12% |
| 2020 | 2.08% |
| 2019 | 28.03% |
NVS Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching NVS
Want to see what other sources are saying about Novartis Ag's financials and stock price? Try the links below:Novartis Ag (NVS) Stock Price | Nasdaq
Novartis Ag (NVS) Stock Quote, History and News - Yahoo Finance
Novartis Ag (NVS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...